October 15, 2015 / 12:31 PM / 3 years ago

BUZZ-U.S. STOCKS ON THE MOVE-Citigroup, Valeant, Netflix

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock index futures rose on Thursday as investors await key economic data and earnings reports. Dow Jones industrial average futures were up 0.52 percent at 16,909, S&P 500 futures were up 0.74 percent at 1,998.75 and Nasdaq 100 futures were up 0.83 percent at 4,362.25.

** TRANSITION THERAPEUTICS INC, Wednesday close $1.93, +15.03 pct premarket

The drug developer said its experimental drug reduced severe agitation and aggression in Alzheimer’s patients, citing data from a large study.

** UNITEDHEALTH GROUP INC, Wednesday close $122.07, -1.25 pct premarket

The largest U.S. health insurer reported a better-than-expected profit in the third quarter, helped by higher revenue from its Optum pharmacy management business and new enrollments.

** CITIGROUP INC, Wednesday close $50.72, +2.92 pct premarket

The third biggest U.S. bank by assets reported a 51 percent rise in quarterly profit as a fall in operating, legal and repositioning costs more than made up for lower revenue.

** GOLDMAN SACHS GROUP INC, Wednesday close $179.51, -1.34 pct premarket

The Wall Street bank reported a sharp drop in profit for the second straight quarter as bond trading revenue fell by a third amid turmoil stemming from concerns about global growth.

** WAL-MART STORES INC, Wednesday close $60.03, -0.77 pct premarket

The world’s biggest retailer warned on Wednesday that higher wages as well as spending on e-commerce and lower prices would cut earnings per share as much as 12 percent next fiscal year.

** VALEANT PHARMACEUTICALS INTERNATIONAL INC, Wednesday close $177.29, -10.59 pct premarket

The Canadian drugmaker, under fire for price increases of its two heart drugs, said it was subpoenaed by U.S. prosecutors on its pricing, drug distribution and patient assistance programs.

** NETFLIX INC, Wednesday close $110.23, -4.02 pct premarket

The video-streaming service provider reported third-quarter U.S. subscriber additions below its own forecast, blaming a transition to chip-based cards for the miss.

** BRISTOL-MYERS SQUIBB CO, Wednesday close $62.08

** FIVE PRIME THERAPEUTICS INC, Wednesday close $16.91

Drugmaker Bristol-Myers Squibb said it agreed to exclusively license and collaborate with Five Prime to develop and commercialize Five Prime’s antibody program in the treatment of cancer.

** NIKE INC, Wednesday close $125.84, +0.92 pct premarket

The world’s largest sportswear maker’s revenue is set to grow faster over the next five years than it had in the previous five. Nike said it expects revenue to increase 63 percent to $50 billion by fiscal 2020, boosted by growth in its e-commerce, women’s and Jordan brand businesses.

** HCA HOLDINGS INC, Wednesday close $76.02

The largest for-profit U.S. hospital operator estimated third-quarter profit that fell short of analysts’ expectation, hurt by higher labor costs and less favorable payer mix.

** LOCKHEED MARTIN CORP, Wednesday close $208.15

** UNITED TECHNOLOGIES CORP, Wednesday close $92.17

Defence equipment maker Lockheed Martin Corp’s $9 billion purchase of Sikorsky Aircraft from United Technologies could close by late October or early November, well before the initial year-end target, three sources familiar with the matter said on Wednesday.

** CHARTER COMMUNICATIONS INC, Wednesday close $182.75

** TIME WARNER CABLE INC, Wednesday close $186.17

Wireless carrier AT&T Inc said it does not oppose the proposed merger of Charter Communications and Time Warner Cable, but in a letter to the U.S. Federal Communications Commission it asked for a careful review on the impact of cable deals on emerging online video products.

** UNILEVER PLC, Wednesday close $43.11, +4.50 pct premarket

The consumer goods maker reported better-than-expected third-quarter sales, but said sluggish markets globally continued to weigh on its performance.

** PFIZER INC, Wednesday close $33.04

U.S. health regulators declined to approve the drugmaker’s oral rheumatoid arthritis drug Xeljanz to treat moderate to severe cases of the scaly skin condition plaque psoriasis, the company said on Wednesday.

** SYNGENTA AG, Wednesday close $62.93

Third-quarter sales at the Swiss agricultural chemicals group fell by more than expected as the weak currency in Brazil, its second-largest market, eroded the value of overseas business.

** BHP BILLITON LTD, Wednesday close $36.67, -0.08 pct premarket

The world’s biggest mining company was on course to raise $6.5 billion-equivalent on Wednesday through one of the largest hybrid bonds ever seen out of the corporate sector.

** SCHLUMBERGER LTD, Wednesday close $75.01, -0.21 pct premarket

The world’s No.1 oilfield services provider is expected to report a steep fall in third-quarter profit as lower oil prices weigh on global drilling activity. Investors will be looking out for any updates on the company’s move to buy equipment maker Cameron International. (Compiled by Kshitiz Goliya in Bengaluru; Editing by Maju Samuel)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below